RXI Pharma (RXII) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts RXII Hot Sheet
Join SI Premium – FREE
RXI Pharma (NASDAQ: RXII) reported Q4 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05).
For earnings history and earnings-related data on RXI Pharma (RXII) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
